Consistent with this concept, up to 30% of individuals with PsO eventually develop PsA, a chronic inflammatory arthropathy affecting peripheral joints, entheses, and the axial skeleton ( Early PsA may display nonspecific musculoskeletal symptoms, such as inflammatory arthralgia or morning stiffness, even in the absence of overt synovitis or radiographic erosions ( At the pathogenic level, PsO and PsA share core inflammatory mechanisms driven by dysregulation of the IL17/IL23 and Tumour Necrosis Factor (TNF)- cytokine axes ( These immune pathways are closely intertwined with metabolic abnormalities, particularly obesity and adipose tissue dysfunction
The food noise was silenced, which has been the most refreshing thing
Chronic Obstructive Pulmonary Disease (incidence 2%): viral infection, headache, nasopharyngitis, back pain, diarrhea, arthralgia, urinary tract infection, local administration reactions, rhinitis, eosinophilia, toothache, and gastritis
The Dual GlucoseDependent Insulinotropic Peptide and GlucagonLike Peptide1 Receptor Agonist, Tirzepatide, Improves Lipoprotein Biomarkers Associated With Insulin Resistance and Cardiovascular Risk in Patients With Type 2 Diabetes